CoChat

Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database

Open access
Kubitz, Nicole, Mehra, Maneesha, Potluri, Ravi C., Garg, Nitesh, Cossrow, Nicole · 2013 · PLoS ONE
Cited by 143

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

CONTEXT: Treatment Resistant Depression (TRD) is a significant and burdensome health concern. OBJECTIVE: To characterize, compare and understand the difference between TRD and non-TRD patients and episodes in respect of their episode duration, treatment patterns and healthcare resource utilization. DESIGN AND SETTING: Patients between 18 and 64 years with a new diagnosis of major depressive disorder (MDD) and without a previous or comorbid diagnosis of schizophrenia or bipolar disease were included from PharMetrics Integrated Database, a claims database of commercial insurers in the US. Episodes of these patients in which there were at least two distinct failed regimens involving antidepressants and antipsychotics were classified as TRD. PATIENTS: 82,742 MDD patients were included in the analysis; of these patients, 125,172 episodes were identified (47,654 of these were drug-treated episodes). MAIN OUTCOME MEASURES: Comparison between TRD and non-TRD episodes in terms of their duration, number and duration of lines of treatment, comorbidities, and medical resource utilization. RESULTS: Of the treated episodes, 6.6% (N = 3,134) met the criteria for TRD. The median time to an episode becoming TRD was approximately one year. The mean duration of a TRD episode was 1,004 days (vs. 452 days for a non-TRD episode). More than 75% of TRD episodes had at least four lines of therapy; half of the treatment regimens included a combination of drugs. Average hospitalization costs were higher for TRD than non-TRD episodes: $6,464 vs. $1,734, as were all other health care utilization costs. CONCLUSIONS: While this study was limited to relatively young and commercially covered patients, used a rigorous definition of TRD and did not analyze for cause or consequence, the results highlight high unmet medical need and burden of TRD on patients and health care resources.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0076882

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 9

  1. Hirschfeld RMA, Weissman MM (2002) Risk Factors For Major Depression And Bipolar Disorder. Neuropsychopharmacology: The Fifth Generation of Progress Section 8: Chapter 70.
  2. DL Musselman, 1998, The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment, Arch Gen Psychiatry, 55, 580, 10.1001/archpsyc.55.7.580 · DOI · Paper page
  3. JI Ivanova, 2010, Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder, Curr Med Res Opin, 26, 2475, 10.1185/03007995.2010.517716 · DOI
  4. MB Keller, 2005, Issues in treatment-resistant depression, J Clin Psychiatry, 66, 5
  5. E Vieta, 2011, Therapeutic options in treatment-resistant depression, Ann Med, 43, 512, 10.3109/07853890.2011.583675 · DOI · Paper page
  6. TB Gibson, 2010, Cost burden of treatment resistance in patients with depression, Am J Manag Care, 16, 370
  7. D Souery, 1999, Treatment resistant depression: methodological overview and operational criteria, Eur Neuropsychopharmacol, 9, 83, 10.1016/S0924-977X(98)00004-2 · DOI · Paper page
  8. CB Nemeroff, 2007, Prevalence and management of treatment-resistant depression, J Clin Psychiatry, 68, 17
  9. NS Philip, 2010, Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era, Expert Opin Pharmacother, 11, 709, 10.1517/14656561003614781 · DOI

Cited by

See all 143

Metadata

Authors
Kubitz, N., Mehra, M., Potluri, R. C., Garg, N., & Cossrow, N.
Venue
PLoS ONE
Published
2013-10-18
Volume
8
Issue
10
Pages
e76882
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2024075080
Cited by
143
References
9
FWCI
2.39
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database. https://app.cochat.ai/papers/10.1371/journal.pone.0076882
The paper
Kubitz, N., Mehra, M., Potluri, R. C., Garg, N., & Cossrow, N. (2013). Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database. PLoS ONE. https://doi.org/10.1371/journal.pone.0076882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.